QA: Keenova Therapeutics plc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001567892_2021_Keenova_Therapeutics_plc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001567892, Keenova Therapeutics plc

  xvar xval
0 AssetsCurrent 2,304,300,000
1 IntangibleAssetsNetIncludingGoodwill 6,184,500,000
2 PropertyPlantAndEquipmentNet 833,100,000
3 remainder_Assets 393,500,000
4 LiabilitiesCurrent 4,118,700,000
5 LiabilitiesNoncurrent 109,800,000
6 remainder_Liabilities 4,467,700,000
7 CostOfGoodsAndServicesSold 1,544,000,000
8 SellingGeneralAndAdministrativeExpense 884,100,000
9 ResearchAndDevelopmentExpense 290,800,000
10 remainder_Expenses 1,030,100,000
11 remainder_Revenues 2,213,400,000
12 remainder_NetIncome 55,000,000
13 remainder_ComprehensiveNetIncome -1,700,000
  yvar yval
0 Assets 9,715,400,000
1 Liabilities 8,696,200,000
2 Expenses 3,749,000,000
3 Revenues 2,213,400,000
4 StockholdersEquity 1,019,200,000
5 NetIncome -1,480,600,000
6 ComprehensiveNetIncome -1,481,450,000
7 BaseVar 12,215,350,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.0804
9 EconomicCapitalRatio 1.49

Edgar->Model Mapping

Feature Distribution